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Retinal orientation and interactions in rhodopsin
reveal a two-stage trigger mechanism for activation
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Ekaterina Zaitseva4, Reiner Vogel5, Mordechai Sheves3, Philip J. Reeves2 & Steven O. Smith1
The 11-cis retinal chromophore is tightly packed within the interior of the visual receptor
rhodopsin and isomerizes to the all-trans conﬁguration following absorption of light. The
mechanism by which this isomerization event drives the outward rotation of transmembrane
helix H6, a hallmark of activated G protein-coupled receptors, is not well established.
To address this question, we use solid-state NMR and FTIR spectroscopy to deﬁne the
orientation and interactions of the retinal chromophore in the active metarhodopsin II
intermediate. Here we show that isomerization of the 11-cis retinal chromophore generates
strong steric interactions between its b-ionone ring and transmembrane helices H5 and H6,
while deprotonation of its protonated Schiff’s base triggers the rearrangement of the
hydrogen-bonding network involving residues on H6 and within the second extracellular loop.
We integrate these observations with previous structural and functional studies to propose a
two-stage mechanism for rhodopsin activation.
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T
he visual receptor rhodopsin is a member of the family A G
protein-coupled receptors (GPCRs)1,2. These receptors
share a seven transmembrane (TM) helix architecture
and the ability to activate heterotrimeric G proteins, yet they
respond to a wide array of ligands ranging from small-molecule
odorants in the olfactory receptors to peptide ligands in the
hormone and chemokine receptors1,2. The diversity between
receptor subfamilies largely lies in the extracellular, ligand-
binding region, which has evolved to recognize and respond to
different types of signals3,4. The extracellular loops and
extracellular ends of the TM helices contain many subfamily-
speciﬁc residues, while most of the sites with high sequence
conservation across the family A GPCRs are found in the TM
core and intracellular G protein-binding cavity1,5. A common
feature of GPCR activation is the outward rotation of the
intracellular end of TM helix H6, which serves to expose the G
protein-binding site6–8. Nevertheless, the molecular mechanism
by which this intracellular motion is achieved on extracellular
binding of such diverse ligands remains largely unresolved.
Rhodopsin provides an ideal model system for addressing the
activation mechanism of family A GPCRs. Its light-sensitive
retinal chromophore is covalently bound via a protonated Schiff’s
base (PSB) linkage to Lys2967.43 (superscripts denote generic
Ballesteros–Weinstein numbering of GPCRs9) in the interior of
the protein. This covalent attachment ensures full ligand
occupancy, a desirable property for structural studies. The
retinal-binding site has evolved to accommodate the 11-cis
isomer of the retinal PSB10, which acts as an inverse agonist
and locks the receptor in a fully off-state. Photochemical
isomerization and deprotonation of the PSB forms an all-trans
retinal SB chromophore, which acts as a full agonist for receptor
activation. That is, rhodopsin functions as a molecular off–on
switch; it is designed to be fully inactive in the dark and to rapidly
convert to a fully active structure in the light. This activation
process differs from GPCRs that bind diffusible agonists where
the signalling status is more complex and governed by an
equilibrium between ligand-bound and ligand-free states11.
The crystal structure of the apoprotein opsin6,7 and
constitutively active mutants of rhodopsin12,13 have provided
several key insights into the conformational changes that occur
on receptor activation. These structures conﬁrm the large
outward rotation of H6, the signature of an active receptor14.
However, despite the large change in retinal conﬁguration and
orientation, the active-state crystal structures of rhodopsin show
almost no change in structure on the extracellular side of the
receptor when compared with the large changes observed on the
intracellular side15. This observation is surprising as a substantial
amount of absorbed light energy (B35 kcalmol 1) is stored
within retinal–protein interactions in the primary photoproduct
bathorhodopsin16 and then released as the retinal and
surrounding protein relax during the transition to the active
metarhodopsin II (Meta-II) intermediate2. The lack of structural
changes in the binding site surrounding the retinal raises the
question of how retinal isomerization and PSB deprotonation
generate the large helix rearrangements on the intracellular side
to create the intracellular G protein-binding pocket.
We take advantage of solid-state nuclear magnetic resonance
(NMR) and Fourier transform infrared (FTIR) spectroscopy
of Meta-II to address how protein residues within the 11-cis
retinal-binding site adapt to the constrained all-trans retinal
conﬁguration following retinal isomerization. We also gain
insight into how hydrogen-bonding networks on the extracellular
surface of rhodopsin rearrange in response to PSB deprotonation.
Low temperature (below B0 C) slows the thermal steps in the
rhodopsin photoreaction and provides a way to trap the native
light-activated Meta-II state17–19. In contrast, high-resolution
crystal structures, which capture elements of the active state, rely
on soaking crystals of the apoprotein opsin with all trans-retinal20
or have required stabilizing and/or activating mutations12,13.
Crystals of native rhodopsin crack and no longer diffract
following absorption of light and conversion to an active
conformation21. Structural information from solid-state NMR
experiments comes from distance measurements between speciﬁc
13C labels incorporated into the retinal and the protein,
as well as from chemical shift measurements to assess changes
in hydrogen bonding. Nevertheless, this approach relies on the
crystal structures as a reference to establish how speciﬁc sites
change position or orientation on activation. FTIR difference
spectroscopy provides a complementary approach to NMR for
assessing how speciﬁc residues in close association with the
retinal control the equilibrium between Meta-I and Meta-II,
the ﬁnal step in the reaction pathway22–24.
The ﬁrst major observation to emerge from these studies is that
the orientation of the retinal differs in Meta-II trapped along its
reaction coordinate compared with Meta-II stabilized for
crystallography. NMR constraints indicate that the b-ionone ring
does not change orientation on activation, but rather the largest
change in retinal structure involves rotation of the C20 methyl
group toward extracellular loop-2 (EL2)18. In contrast, crystal
structures obtained by diffusing all-trans retinal into opsin
(Meta-II-opsin20) or using the constitutively active M257Y
mutant25 (Meta-II-M257Y; ref. 13) suggest that the all-trans
retinal SB is in an orientation roughly opposite to that observed
by NMR (Supplementary Fig. 1). The second major observation is
that there are larger changes in the position of key aromatic
residues (Tyr191EL2 and Tyr2686.51) surrounding the retinal than
observed in the crystal structures. These residues are highly
conserved in the visual receptor subfamily. FTIR studies of the
Y191F and Y268F mutants indicate that these tyrosines control
the Meta-I 3 Meta-II equilibrium. We propose an activation
mechanism that builds on these observations and previous studies
by emphasizing the changes in extracellular residues in close
proximity to the retinal. The mechanism that emerges from these
studies implicates steric interactions as the dominant force
driving structural changes in the light-triggered transition of
rhodopsin to Meta-I, while electrostatic (and hydrogen bonding)
interactions control the formation of the active Meta-II
conformation.
Results
Retinal orientation in Meta-II. To establish the orientation of
the retinal in the binding site of the active Meta-II intermediate,
we focus on the positions of the retinal C18, C19 and C20 methyl
groups relative to surrounding protein residues (Fig. 1 and
Supplementary Fig. 1). The C19 and C20 methyl groups extend
from the retinal polyene chain, while the C18 methyl group
extends from the b-ionone ring. In the crystal structures of
Meta-II obtained using the M257Y mutant13 or with opsin
containing the bound retinal SB20, the b-ionone ring has rotated
relative to its position in rhodopsin, with the C18 methyl group
facing the extracellular surface. In these models, the closest
tyrosine residue to the C18 methyl group is Tyr191EL2
(Supplementary Note 1 and Supplementary Tables 1–5). Below,
we use NMR to measure a few speciﬁc distances between the
retinal and surrounding protein to deﬁne the orientation of the
retinal in Meta II. These constraints along with the results from
previous biophysical and biochemical studies are used to suggest
a general mechanism of receptor activation.
NMR distance measurements between 13C sites in the retinal
and surrounding protein are made using dipolar-assisted
rotational resonance (DARR) of rhodopsin and Meta-II
(Supplementary Fig. 2). To address the orientation of the
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retinal b-ionone ring, DARR NMR measurements were made
using rhodopsin containing 13C-ring-labelled phenylalanine
and 13Cz-labelled tyrosine, and regenerated with 13C5,
13C18-labelled retinal. The diagonal 13C resonances in
two-dimensional (2D) DARR NMR spectra arise from
13C-labelled amino acids and retinal. Crosspeaks appear
between resonances when the distance between the 13C atoms
is o6–6.5Å.
Rows taken from 2D NMR spectra of rhodopsin (Fig. 1c, top
panel, black) and Meta-II (Fig. 1c, bottom panel, red) correspond
to the regions containing crosspeaks between 13C resonances. In
rhodopsin, we observe an intense crosspeak between the two
directly bonded retinal carbons, 13C5 at 131.0 p.p.m. and 13C18 at
21.6 p.p.m. There are also crosspeaks atB129 and 137 p.p.m. that
correspond to the chemical shifts of the aromatic ring carbons of
13C-labelled phenylalanine. Phe2616.44 is the only phenylalanine
within the upper distance limit (B6.5 Å) of the DARR
measurements (Supplementary Tables 1–5). The intensities of
the crosspeaks are consistent with the short internuclear distances
(4.9–5.4 Å) between the retinal C18 methyl and the ring carbons
of Phe2616.44 observed in the crystal structure of rhodopsin
(PDB-ID 1U19)26.
On conversion to Meta-II, the retinal 13C resonances change
frequency due to changes in retinal structure, protonation state
and retinal–protein interactions. For example, the crosspeak
between the 13C5 and 13C18 resonances shifts from 131 to
126 p.p.m. (Fig. 1c), but the crosspeak intensity remains the same
because of the ﬁxed distance between these two carbons. The
intra-retinal C5-C18 crosspeak provides an internal control for
calibrating the intensity changes observed in protein–retinal
crosspeaks. The intra-retinal 13C8-13C19 and 13C12-13C20
crosspeaks provided similar internal controls in Fig. 1d,e. The
intensity of the crosspeaks between the retinal and Phe2616.44
ring-13C resonances remains approximately the same as in
rhodopsin, indicating that there is little change in the distance
between Phe2616.44 and the 13C18 methyl group. This observa-
tion argues that the b-ionone ring does not ﬂip as suggested by
the Meta-II crystal structures. The position of the b-ionone ring is
additionally constrained by contacts between the 13C5, 13C18 and
the 13C16, 13C17 retinal resonances and residues (Met2075.42 and
His2115.46) on H5 (Supplementary Fig. 3 and Supplementary
Note 2). Furthermore, in the Meta-II-opsin and Meta-II-M257Y
crystal structures, the rotation of the b-ionone ring is predicted to
bring the C18 methyl group to within the DARR distance limit
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Figure 1 | Retinal–protein contacts in dark-state rhodopsin and Meta-II. (a) Structure of the 11-cis retinal PSB and all-trans retinal SB in rhodopsin and
Meta-II, respectively. (b) Crystal structure of rhodopsin (PDB-ID 1U19; ref. 26) showing interactions of the C18, C19 and C20 retinal methyl groups with
surrounding residues. (c) Retinal C18 contacts with phenylalanine and tyrosine in rhodopsin and Meta-II. Rows through the 13C18 diagonal resonance are
shown from 13C DARR NMR experiments of rhodopsin (black) and Meta-II (red) obtained with the receptor regenerated with 13C5, 13C18 retinal and
incorporating 13C-ring-labelled phenylalanine and 13Cz-labelled tyrosine. Since the chemical shifts can change between rhodopsin and Meta-II, the rows
selected correspond to the diagonal chemical shifts of the 13C18 resonance in rhodopsin at 21.6 p.p.m. and Meta-II at 20.9 p.p.m. These rows maximize the
crosspeak intensities. (d) Retinal C19 contacts with tyrosine. Rows through the 13C19 diagonal resonances in rhodopsin (black) at 14.7 p.p.m. and Meta-II
(red) at 13.8 p.p.m. obtained with the receptor regenerated with 13C8, 13C19 retinal and incorporating 13C-ring Phe and 13Cz-labelled Tyr. (e,f) Retinal C12,
C20 contacts with tyrosine in rhodopsin and Meta-II. Rows through the 13C20 diagonal resonances in rhodopsin (black) at 16.4 p.p.m. and Meta-II (red) at
13.7 p.p.m. obtained with the receptor regenerated with 13C12, 13C20 retinal and incorporating 13Cz-labelled Tyr. (g) Build-up curves for the observed
retinal–tyrosine crosspeaks in rhodopsin (black) and Meta-II (red) scaled to the C12-C20 crosspeaks. The C12-C20 retinal distance is ﬁxed atB2.4Å. The
retinal C12 and C20 distances to the Cz carbon of Tyr2686.51 range from B4 to 6Å (Supplementary Table 3). The retinal-Tyr2686.51 data are compared
with build-up curves derived from model compounds and ﬁxed distances in rhodopsin. The error in the measurements is ±0.3Å on the basis of the
signal-to-noise of the NMR spectra. (h) 13Cz-Tyr2686.51 crosspeaks with the retinal 13C10,11 resonances (top) and the 13C14,15 resonances in rhodopsin
(black) and Meta-II (red). Rows are taken through the 13Cz-Tyr diagonal resonance at 155.2 p.p.m. in rhodopsin and 156.1 p.p.m. in Meta-II.
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(B6Å) of 13Cz-Tyr191EL2, which is not observed in the present
studies (Fig. 1c).
The C19 methyl group provides another probe of the retinal
orientation. In rhodopsin, the C19 methyl is oriented towards
EL2 and packed between Thr1183.33, Tyr191EL2, Ile189EL2
and Tyr2686.51 (Fig. 1b). We observe two C19-13Cz-tyrosine
crosspeaks at 155.2 and 156.6 p.p.m. (C19-Tyr2686.51, 4.3 Å; and
C19-Tyr191EL2, 4.7 Å) (Fig. 1d). In Meta-II, the 13C19-13Cz-
tyrosine crosspeak intensity is lost, consistent with an increased
separation between these tyrosines and the retinal C19 methyl
group to 4B6–6.5 Å. We had previously attributed the loss of
C19-tyrosine crosspeak intensity to translational motion of the
retinal towards H5 and motion of EL2 (ref. 27). Below, we now
show that the chemical shifts of both Tyr191EL2 and Tyr2686.51
change in Meta-II, suggesting that they move as well. This
contributes to the loss of crosspeak intensity between the retinal
C19 methyl resonance and the overlapping 13Cz-Tyr191EL2 and
Tyr2686.51 resonances. Moreover, we show that the alternative
explanation, a ﬂip of the b-ionone ring, does not occur until
Meta-II decays (Supplementary Fig. 4 and Supplementary
Note 3).
The retinal C20 methyl group is twisted out of the plane of
the retinal polyene chain and primed to rotate in the
clockwise direction when viewed from the Schiff’s base end of
the retinal28–30. We previously concluded that the C20 methyl
rotates towards EL2 on the basis of a C20-Tyr2686.51
crosspeak18,19. Here NMR measurements on the orientation
of the C20 methyl group were undertaken with rhodopsin
13C-labelled at the z-carbon of tyrosine and regenerated with
13C12, 13C20 retinal (Fig. 1e,f). The row from the 2D DARR
NMR spectrum of rhodopsin (black) through the C20 diagonal
resonance yields an intense C12-C20 crosspeak at 132.2 p.p.m.
(internal control) and a strong crosspeak to 13Cz-Tyr2686.51 at
155.2 p.p.m. (refs 18,19). On conversion to Meta-II (red), the
C20-Tyr2686.51 crosspeak is only modestly weaker relative to the
C12-C20 intra-retinal crosspeak, whereas the C12-Tyr2686.51
crosspeak becomes markedly weaker.
The crosspeak intensities between the 13Cz-Tyr2686.51 and the
retinal 13C12,13C20 resonances constrain the position of the
tyrosine side chain relative to the retinal. The large difference in
intensity in Meta-II between the C12 and C20 crosspeaks with
Tyr2686.51 indicate that the C20 methyl group is closer to
the tyrosine-Cz carbon than the C12 methyl group. Molecular
dynamics simulations performed on the basis of previous
NMR constraints28 generated similar distances (B4.3 Å)
between Tyr2686.51 and the C12 and C20 carbons in Meta-II
(Supplementary Table 3). The current NMR measurements
indicate that the C20-Tyr2686.51 separation (B4.4 Å) is shorter
than the C12-Tyr2686.51 separation (B5.6 Å). In contrast, the
X-ray structures of Meta-II show the reverse, namely,
the C12-Tyr2686.51 separation is shorter (B3.9 Å) than the
C20-Tyr2686.51 separation (B5.9 Å). To accommodate the NMR
distances, we propose (see below, Supplementary Fig. 5 and
Supplementary Note 4) that H6 tilts inward on activation, a
motion that is not captured in the molecular dynamics
simulations.
Figure 1g presents build-up curves of crosspeak intensity for
the retinal C12 and C20 carbons and Tyr2686.51. These curves
provide a more accurate measure of internuclear distance than
measurements at a single mixing time31,32. The distances in
rhodopsin (black symbols) derived from this experiment are
consistent with crystal structure distances (C12-Tyr2686.51, 4.5 Å;
C20-Tyr2686.51, 4.1 Å; PDB-ID 1GZM (ref. 33)). In contrast, in
Meta-II (red symbols) there is a marked difference between the
distances estimated on the basis of the NMR build-up curves and
the distances taken from the Meta-II crystal structures
(Supplementary Table 3). For example, in the Meta-II-opsin
and Meta-II-M257Y structures, the C12 carbon is much closer to
the extracellular surface and consequently is in closer proximity
to Tyr2686.51 than C20. The crystal structures place C12 at a
distance of 3.8–4.0Å from Tyr2686.51 (Supplementary Table 3),
which should give rise to a stronger NMR crosspeak than
observed. The intensity of the C12-Tyr2686.51 crosspeak drops
considerably between rhodopsin and Meta-II indicating an
increase in distance of C12 from Tyr2686.51. The NMR-derived
distance is estimated to be B5.6±0.3 Å. Together, the NMR
distance constraints presented above indicate that the orientation
of the retinal in Meta-II trapped along its reaction coordinate is
different than in the crystal structures.
Tyr268 movement suggests an inward tilt of H6 in Meta-II.
Tyr2686.51 has the highest subfamily conservation (97%) in the
visual GPCRs after Lys2967.43, the site of retinal attachment,
indicating that its position and interactions are critically
important within the visual receptors. A change in the position of
Tyr2686.51 in Meta-II is detected by monitoring tyrosine cross-
peaks to the retinal 13C10, 13C11 and the 13C14, 13C15 carbons.
Tyr2686.51 exhibits crosspeaks to both the retinal 13C10 and
13C11 resonances in rhodopsin (Fig. 1h). These carbons areB4Å
from the Cz position of Tyr2686.51 in the rhodopsin crystal
structures. In contrast, no crosspeak intensity is observed between
the retinal 13C14, 13C15 resonances and the 13Cz resonance of
Tyr2686.51 in rhodopsin. On conversion to Meta-II, the intensities
of both the 13C10 and 13C11 crosspeaks to Tyr2686.51 decrease,
while the 13C14 and 13C15 crosspeaks increase. Together, these
changes indicate a shift in the position of Tyr2686.51 towards the
Schiff base linkage in Meta-II.
The shift of Tyr2686.51 towards the retinal C14 and C15
carbons argues for a location between the retinal and EL2. We
also observe strong chemical shift changes in the region of the SB
consistent with a change in its electrostatic environment34. The
retinal C15¼N bond is strongly polarized; a large downﬁeld
chemical shift of C15 on conversion to Meta-II indicates that
this carbon bears a substantial partial positive charge. The
C¼N polarization suggests close interactions with Glu1133.28,
Glu181EL2 and/or Tyr2686.51.
The movement of Tyr2686.51 towards EL2 is supported by
changes in the intensity of crosspeaks to Gly188EL2 and
Cys187EL2 in Meta-II (Fig. 2). We have previously shown that
Tyr2686.51 exhibits a weak crosspeak with Gly188EL2 in
rhodopsin27. 2D NMR spectra using rhodopsin containing
13Ca-Gly, 13Cz-Tyr and 13C¼O-Cys allow us to highlight the
Cys187EL2-Gly188EL2 pair since the Cys-13C¼O to Gly-13Ca
distance is short (2.4 Å) and consequently yields an intense
crosspeak. As with the double 13C-labelled retinals, the
Cys187EL2-Gly188EL2 pair serves as an internal control since
the distance between these labelled 13C sites does not change
between rhodopsin and Meta-II (Fig. 2b).
On conversion to Meta-II, we observe two 13Ca-Gly-13Cz-Tyr
crosspeaks (Fig. 2b). The weaker crosspeak at 44.5 p.p.m. in
Meta-II is assigned to Gly1143.29-Tyr178EL2 on the basis of the
Y178F mutant (Fig. 2f). The stronger crosspeak at 43.1 p.p.m. is
assigned to an overlap of the Gly188EL2-Tyr2686.51 crosspeak and
at least one other Tyr-Gly contact. There is considerable loss of
intensity at this position in the G188A mutant, and complete loss
of the Cys187EL2-Gly188EL2 crosspeak (Fig. 2e).
The Cys187EL2 13C¼O label provides an additional probe for
the location of Tyr2686.51 in Meta-II. There are two Cys-Tyr pairs
in rhodopsin that are o6Å apart (Tyr1363.51-Cys1403.55, 5.1 Å;
and Tyr2065.41-Cys1674.56, 5.9 Å; PDB-ID 1U19 (ref. 26)). Both
Tyr-Cys distances increase to 46Å in the opsin crystal
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structure6. We observe a weak crosspeak in rhodopsin between a
Cys-13C¼O resonance (168–172 p.p.m.) and a Tyr-13Cz
resonance (B156 p.p.m.; Fig. 2c). We observe two stronger
crosspeaks in Meta-II at 172.5 p.p.m. (Fig. 2d), the same shift as
the Cys187EL2 13C¼O deﬁned in Fig. 2b. One of the tyrosine
contacts can be assigned to Tyr191EL2 on the basis of its unique
13Cz chemical shift at 159.3 p.p.m. (ref. 18). We assign the other
crosspeak to a Cys187EL2-Tyr2686.51 interaction.
The position of the 13Cz-Tyr2686.51 relative to 13C15-labelled
retinal, as well as to 13Ca-Gly188 and 1-13C-Cys187, indicates
that Tyr2686.51 has shifted in the retinal-binding site. The
separation between the 13Cz Tyr2686.51 carbon and these sites is
46Å in the Meta-II crystal structures, but much shorter in
Meta-II trapped in the NMR experiments. The shorter distance is
consistent with a small inward tilt of the extracellular end of H6.
In addition to the crosspeak of retinal C20 with Tyr2686.51 in
Meta-II (Fig. 1e), the C20 methyl group also exhibits a crosspeak
with a glycine having a chemical shift of 46.5 p.p.m., which is
assigned to Gly1213.36 on the basis of mutational studies
(Supplementary Fig. 5 and Supplementary Note 4). Together,
the retinal C20-Tyr2686.51 and -Gly1213.36 contacts indicate that
the orientation of the C20 methyl group is roughly halfway
between the orientation found in the Meta-II crystal structures
and the orientation that previously resulted from molecular
dynamics simulations (Supplementary Fig. 1).
Extracellular tyrosine switch releases constraints on H6.
Tyr2686.51 on TM helix H6 is strongly hydrogen-bonded to
Glu181EL2 on the b3 strand of EL2 and to Tyr191EL2 on the b4
strand of EL2 (Fig. 3d and Supplementary Table 5). EL2 caps the
extracellular side of the retinal-binding site and Glu181EL2 has
previously been identiﬁed as a second counter-ion to the retinal
PSB, shifting position in the transition of rhodopsin to the Meta-I
intermediate35. As a result, Tyr2686.51 is in a key location to
couple hydrogen-bonding changes involving EL2 and the retinal
PSB with motion of H6. The NMR data discussed above show
that Tyr2686.51 has shifted relative to the retinal in Meta-II, while
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Figure 2 | Tyr2686.51 to Gly188EL2 and Tyr2686.51 to Cys187EL2 contacts in Meta-II. (a) 2D DARR spectrum highlighting Tyr-Gly contacts in rhodopsin
using rhodopsin containing 13Cz-Tyr, 13Ca-Gly and 13C¼O-Cys. In the rhodopsin crystal structure (PDB-ID 1U19; ref. 26), there are six Tyr(Cz)-Gly(Ca)
contacts, which are all located in the extracellular region of rhodopsin. These contacts involve ﬁve tyrosines and ﬁve glycines: Tyr10N term-Gly3N term,
3.9Å; Tyr10N term-Gly280EL3, 4.4Å; Tyr29N term-Gly101EL1, 4.0Å; Tyr178EL2-Gly1143.29, 4.5Å; Tyr191EL2-Gly188EL2, 5.2Å; and Tyr2686.51-Gly188EL2,
5.3Å. Above a are shown rows through the Tyr-Gly crosspeaks. The rows better illustrate the intensity change occurring in the Tyr2686.51-Gly188EL2 peak
on activation. The observation that the Tyr178EL2-Gly1143.29 crosspeak does not change intensity is consistent with the lack of inﬂuence of the Y178F
mutation on the Meta-I–Meta-II transition (Fig. 4g). (b) Wild-type Meta-II spectrum using rhodopsin containing 13Cz-Tyr, 13Ca-Gly and 13C¼O-Cys. (c,d)
Region of the 2D DARR spectra of rhodopsin (black) and Meta-II (red) corresponding to 13Cz-Tyr to 13C¼O-Cys crosspeaks. Above c are shown rows
through the 13Cz-Tyr diagonal of rhodopsin and Meta-II. (e,f) G188A Meta-II and Y178F Meta-II spectra, respectively, using the same 13C-labelling scheme
as above. Rows are shown through the Tyr-Gly crosspeaks in the G188A Meta-II and Y178F Meta-II spectra above e.
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the large downﬁeld chemical shift of Tyr191EL2 suggests that it
has shifted relative to Glu181EL2.
To conﬁrm that the changes in Tyr191EL2 and Tyr2686.51 are
triggered by the shift in the position of Glu181EL2, we obtained
both one-dimensional (1D) difference NMR spectra and 2D
DARR NMR spectra (Supplementary Fig. 6 and Supplementary
Note 5) focusing on residues in close proximity to Glu181EL2. 1D
NMR difference spectra of 13Ce-Met-labelled rhodopsin show
that the side-chain methyl group of Met2887.35 has an unusual
downﬁeld chemical shift in rhodopsin, which moves upﬁeld in
both Meta-I and Meta-II (Fig. 3a). Met2887.35 represents a
contact point between H7 and EL2, and is in close proximity to
Glu181EL2 in the rhodopsin structure. These chemical shift
changes are consistent with the shift of the negatively charged
Glu181EL2 side chain away from the methyl group of Met2887.35.
Motion of Glu181EL2 towards the retinal PSB suggests that it
comes into close proximity with Ser186EL2. 1D difference spectra
of 13Cb-labelled-serine reveal a downﬁeld shift in Meta-I and
upﬁeld shift in Meta-II (Fig. 3b). The chemical shift of the 13Cb
carbon of serine is sensitive to Cb-OH hydrogen bonding, and the
observed chemical shift changes are consistent with increased
hydrogen bonding in Meta-I (or earlier photointermediate)36 and
decreased hydrogen bonding in Meta-II.
In rhodopsin, the chemical shifts of both 13Cz-Tyr191EL2 and
13Cz-Tyr2686.51 are at B156 p.p.m. (Fig. 1d). There is a positive
peak in the rhodopsin–Meta-I difference spectrum at this
position, but no corresponding negative peaks (Fig. 3c). In
contrast, we have previously assigned18,19 the downﬁeld
resonance at 159.3 p.p.m. in the rhodopsin–Meta-II difference
spectrum to Tyr191EL2 and have suggested that this unusual
chemical shift is due to direct interaction with Glu181EL2.
Together, the chemical shift changes of Met2887.35 and
Ser186EL2 indicate that the counter-ion shift of Glu181EL2 in
Meta-I precedes the motion of Tyr191EL2 in Meta-II. Tyr191EL2 is
tightly packed against Ala2726.55 on H6, one helical turn from
Tyr2686.51, and its motion towards Glu181EL2 would release
steric constraints hindering the inward tilt of the extracellular end
of H6 in the dark state.
Conserved extracellular tyrosine residues stabilize Meta-I. The
interactions involving Tyr191EL2, Tyr2686.51 and Met2887.35
indicate that these residues mediate the transition between Meta-I
and Meta-II. To further explore their inﬂuence on activation,
we undertook FTIR studies on the Y191F, Y268F and M288L
mutants alongside wild-type rhodopsin. We previously showed
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FTIR difference spectra were obtained at 0 C as a function of pH, and the relative contributions of Meta-I and Meta-IIbHþ were determined on the
basis of reference spectra (Supplementary Fig. 7). Spectral decomposition was performed between 1,800 and 1,600 cm 1. This range is the most
diagnostic of the Meta-I–Meta-II transition and comprises the amide I vibrations of the protein backbone and the C¼O stretch of protonated carboxylic
acids Glu1223.37 and Asp832.50. The vertical dashed lines are at the positions of the inﬂection points.
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that the amide I infrared band along with the C¼O stretching
modes of the protonated Glu1223.37 and Asp832.50 carboxylic
groups provide conformationally sensitive markers and can be
used to deconvolute the Meta-I3 Meta-II equilibrium into the
inactive Meta-I state and several Meta-II substates (Meta-IIa,
Meta-IIb and Meta-IIbHþ ; Supplementary Fig. 7 and
Supplementary Note 6)22.
A two-state equilibrium is observed at 0 C between Meta-I
and Meta-IIbHþ using wild-type rhodopsin reconstituted into
egg phosphocholine membranes, where the transition between
Meta-I and Meta-IIbHþ has an apparent pK of B6.8 and is
similar for each of these FTIR markers (Fig. 4a). At higher
temperature, the titration curves become more complex with
stabilization of the Meta-IIb substate (Supplementary Fig. 7). The
Y268F, Y191F and M288L mutants exhibit complex titration
curves (Fig. 4b,c,e) even at 0 C due to a strong forward shift of
the Meta-I3 Meta-IIb equilibrium to Meta-IIb. For wild-type
rhodopsin, an increase in temperature will lead to a shift of the
equilibrium as the stabilization of Meta-IIb has an entropic
component22. In contrast for the mutants, the forward shift
reﬂects the loss of stabilizing interactions in Meta-I.
The Y192F mutant (Fig. 4d) exhibits a forward shift of the
Meta-I3Meta-IIb equilibrium as in Y191F, but the effect is not
as large. The M288A mutant (Fig. 4f) reveals a downshift of the
apparent pKa, indicating stabilization of the Meta-I intermediate
on mutation. Thus, depending on the speciﬁc mutation at
Met2887.35, the Meta-I3 Meta-II equilibrium can be shifted in
either direction. Finally, the equilibrium is not affected by the
W175F and Y178F mutants (Fig. 4g,h) indicating that there are
conserved aromatic residues in EL2 that do not have the effects
observed for Tyr191EL2 and Tyr2686.51.
Discussion
Activation of the visual receptors is triggered by changes in both
steric and electrostatic interactions caused by 11-cis to all-trans
isomerization of the retinal and deprotonation of the retinal PSB.
Retinal isomerization occurs in the ﬁrst step of the rhodopsin
photoreaction, while deprotonation occurs on formation of the
Meta-II intermediate37. The speciﬁc retinal–protein interactions
observed by NMR and FTIR provide insights into how these two
components of the activation mechanism work together to drive
the outward tilt of TM helix H6. We liken these connected
activation events to the ﬁring mechanism of a two-stage trigger.
The ﬁrst stage of the trigger results from isomerization-induced
steric contact between the b-ionone ring and residues on helices
H3, H5 and H6 (Fig. 5). NMR38 and ﬂuorescence39 studies both
reveal that the ﬁrst major change in receptor conformation is
rotation of H6 in the formation of Meta-I, which breaks the
intracellular Arg1353.50-Glu2476.30 ionic lock40 and results in
Trp2656.48 displacement38,41. These rearrangements are
accompanied by small changes at the cytoplasmic end of H5
(refs 39,42). Our current results indicate direct contact of the b-
ionone ring with His2115.46 and Phe2616.44 in Meta-II (Fig. 5a).
Previously, we reported that activation results in a loss of the
retinal C18-Trp2656.48 contact19. Mutation of either Phe2616.44
or Trp2656.48 lowers the initial rate of G protein transducin
activation, B20–60% for F261A rhodopsin43 and B90% in
W265F rhodopsin44, consistent with their roles in the activation
mechanism. The steric contact of the b-ionone ring with
Phe2616.44 observed in Meta-II suggests that the phenylalanine
ring acts a lever for rotation of H6. This residue is part of a
transmission switch in the conserved TM core of GPCRs15,45.
The conserved proline (Pro2155.50) on H5 is also a component
of the transmission switch and results in a free backbone carbonyl
at His2115.46. This carbonyl forms an interhelical hydrogen bond
with Glu1223.37 in rhodopsin, which is replaced in Meta-II by a
direct interaction between the His2115.46 and Glu1223.37 side
chains20. The strong steric contacts of the b-ionone ring with
His2115.46 and Glu1223.37 that drive this transition allow H5 to
reorient in Meta-II (ref. 46). Mutation of Glu1223.37 breaks their
direct interaction and destabilizes Meta-II (ref. 47). Retinal
analogues in which the ring is truncated shift the conformational
equilibrium between the Meta-I and Meta-II intermediates
towards the inactive Meta-I state24,48. Thus, the b-ionone ring
is a key element in both the ﬁrst stage of the activation trigger and
in stabilizing the Meta-II intermediate.
In Supplementary Fig. 4, we follow the change in orientation of
the C18 methyl group of the b-ionone ring during the decay of
Meta-II and observe a gain in contact with Tyr191EL2 consistent
with a ﬂip of the b-ionone ring and suggesting that the crystal
structures are capturing a relaxed, low-energy conformation that
has retained the capacity to bind all-trans retinal. The ﬁnal
conformation observed by NMR is possibly Meta-III, in which
the SB is reprotonated49. The observation of an all-trans retinal
PSB following Meta-II suggests that the reprotonation event is the
driving force for rotation along the long axis of the retinal during
Meta-II decay. Together, our NMR results are consistent with the
low temperature trapped Meta-II intermediate being a transient,
high-energy state that is formed along the reaction coordinate
and consequently captures the conformation triggering receptor
activation.
The second stage in the two-stage trigger mechanism involves
deprotonation of the retinal PSB along with steric interactions of
the retinal C19 and C20 methyl groups with Tyr191EL2 and
Tyr2686.51, respectively. Tyr191EL2 and Tyr2686.51 are part of an
extensive hydrogen-bonding network that stretches through
Glu181EL2 to Glu1133.28, the PSB counter-ion (Fig. 5b,
Supplementary Fig. 8 and Supplementary Note 7). Isomerization
results in motion of the retinal PSB proton away from the
stabilizing interaction with Glu1133.28. This ultimately leads to
proton transfer from the PSB to Glu1133.28 in Meta-II. Never-
theless, the change in the position of the PSB proton must already
be sensed by nearby residues in the Meta-I intermediate before
proton transfer. The counter-ion shift mechanism envisions
motion of the charged Glu181EL2 side chain towards the PSB end
of the retinal in Meta-I (ref. 35). The large changes in the NMR
chemical shifts of Ser186EL2 and Met2887.35 observed in Meta-I
are consistent with Glu181EL2 motion. However, motion of
Glu181EL2 in Meta-I precedes the change in the position of
Tyr191EL2 and Tyr2686.51 (Fig. 5b) because the striking downﬁeld
chemical shift of Tyr191EL2 is not observed until Meta-II.
Moreover, the proposed mechanism argues that the tilt of H6
occurs following PSB deprotonation and movement of Tyr191EL2,
in agreement with EPR measurements50. These results are
consistent with an earlier FTIR study suggesting a role for
Tyr268 and H6 reorientation in rhodopsin activation51.
The C19 and C20 methyl groups contribute to the rearrange-
ment of the extracellular hydrogen-bonding network. These
methyl groups extend from the polyene chain and are located on
opposite sides of the cis C11¼C12 bond (Fig. 1a). The crystal
structures of rhodopsin show that the C20 methyl group is
primed to rotate in a clockwise direction on isomerization28–30,
the only potential obstacle being Tyr2686.51. The C20-Tyr2686.51
crosspeak observed in Meta-II by NMR is consistent with
this trajectory of the C20 methyl group and suggests that a
steric contact with Tyr2686.51 contributes to the rearrangement of
the hydrogen-bonding network stabilizing Meta-I on the
extracellular surface of the receptor. In rhodopsin regenerated
with an 11-cis retinal analogue lacking the C20 methyl
group, the photoreaction is slowed52 and the quantum yield is
reduced53.
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The C19 methyl group of retinal is oriented towards EL2 in the
dark state of rhodopsin and is tightly packed between Ile189EL2
and Tyr191EL2 (Supplementary Fig. 8). Retinal analogues lacking
the C19 methyl group cannot activate rhodopsin54, while
increasing the size of the C19 methyl to either an ethyl or
propyl group increases receptor activity in the dark, even though
the retinal still remains covalently bound and in its 11-cis
conﬁguration43,55,56. On isomerization, the C19 methyl group
rotates in the opposite direction (that is, anticlockwise) to the C20
methyl group28–30, and consequently would have increased steric
contact with Tyr191EL2. Removal of the C19 methyl group
eliminates this interaction, while the ethyl or propyl substitutions
at C19 result in a steric clash with Tyr191EL2, which would
disrupt the Tyr191EL2-Tyr2686.51 hydrogen-bonding network in
the dark, in a manner similar to light-driven isomerization in the
wild-type receptor.
The net effect of PSB deprotonation and rearrangement of the
hydrogen-bonding network involving EL2 is a shift of Tyr191EL2
away from H6. We propose that this motion allows the
extracellular end of H6 to pivot inward. In the visual pigments,
Tyr191EL2 has a high level of sequence identity (61%), and
an overall level of conservation of 83% as either tyrosine
or tryptophan. Interestingly, even though Tyr191EL2 and
Tyr2686.51 contribute to Meta-I stability (Fig. 4), mutation of
either of these residues results in a substantial drop in G protein
transducin activation44,57. This dual inﬂuence of Tyr191EL2 and
Tyr2686.51 on Meta-I stability and Meta-II activity is consistent
with one set of hydrogen-bonding interactions stabilizing Meta-I
and a second set stabilizing Meta-II (Fig. 5). The observation that
Tyr191EL2 and Tyr2686.51 strongly stabilize the Meta-I state
suggests that in crystal structures of opsin and/or Meta-II, the
inactive-state hydrogen-bonding network reforms in this region
under the conditions used for crystallization.
The proposed two-stage trigger mechanism builds on the
global toggle switch mechanism developed on the basis of
ligand-activated GPCRs, which envisions a vertical see-saw
movement of helix H6 with conserved Pro2676.50 serving as the
pivot point58. In the case of the visual pigments, Meta-I
corresponds to the inactive state of a ligand-activated GPCR,
where ligand binding simply allows H6 to pivot to open up the
intracellular G protein-binding pocket.
Methods
Expression and puriﬁcation of 13C-labelled bovine rhodopsin. Isotope-enriched
bovine opsin59 was expressed using inducible HEK293S cell lines60, which are
widely used for the production of recombinant proteins and viruses. The primers
used for construction of the rhodopsin mutants are listed in Supplementary
Table 6. The original cell lines were obtained from Jeremy Nathans (Johns Hopkins
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University), but not authenticated or tested for mycoplasma contamination as they
were used only for protein expression. The expressed opsin was generated into
rhodopsin through incubation with B30mM 11-cis retinal and extracted from
membranes using 1% (w/v) n-b-D-dodecyl maltopyranoside (DDM) in PBS pH 7.4.
The detergent-solubilized lysates were separated from the remaining cell debris via
centrifugation at 25,000g for 30min at 4 C. The detergent-solubilized lysate was
applied to a rho-1D4-Sepharose column via gravity ﬂow to capture rhodopsin. The
ﬂow-through volume was saved and the amount of unbound receptor assayed by
western blot using rho-1D4. The column was then washed with 10 volumes of
0.02% DDM in PBS (pH 7.2). A subsequent wash step with 0.02% DDM in sodium
phosphate buffer (pH 6.0) was used to equilibrate the column for elution. The
receptor was then eluted from the rho-1D4-column with 0.02% DDM in sodium
phosphate buffer (pH 6.0) supplemented with a nonapeptide (100 mM) whose
sequence corresponds to the carboxyl terminus of rhodopsin (TETSQVAPA).
For capture of Meta-I, the DDM of the solubilized rhodopsin was reduced to
0.02% w/v and subsequently exchanged for 0.02–0.05% w/v digitonin on the 1D4-
Sepharose column38. Rhodopsin was eluted in 2mM phosphate buffer (pH 7.0)
containing digitonin (0.02–0.05% w/v) and 100mM C-terminal nonapeptide. The
pooled, eluted rhodopsin fractions were concentrated to a ﬁnal volume ofB400 ml
using Centricon devices with a 10 kDa molecular weight cutoff (Amicon, Bedford,
MA), followed by further concentration under argon gas to a volume of B100 ml.
All buffers were prepared fresh before puriﬁcation38.
Synthesis of 13C-labelled retinals. The 13C-labelled retinals were synthesized
using unlabelled and 13C-labelled small molecule precursors. 13C5, 13C18 retinal
was prepared by condensation of 4-bromo-2-methyl-2-butane with 1,2-13C-ethyl
acetoacetate, and conversion of the labelled 6-methyl-5-hepta-2-one to 13C5, 13C18
retinal using conventional methods61. 13C10, 13C11 retinal was synthesized
by condensation of b-ionone with 13CH313CN, which yields labelled
b-ionylideneacetonitrile after dehydration. The latter was converted to 13C10,
13C11 retinal61. 13C12, 13C20 retinal was synthesized using aldol condensation of
2,3-dimethyl-5-(2’,6’,6’-trimethyl-1’-cyclohexene-1’-yl)-2,4-pentadienal with
1,3-13C acetone and conversion to labelled retinal. 13C14, 13C15 retinal was
prepared by condensation of 5,6-dimethyl-8-(2’,6’,6’-trimethyl-1’-cyclohexene-1’-
yl)-3,5,7-octatriene-2-one with di-13C-labelled acetonitrile and transformation to
labelled retinal by conventional methods61. 13C18, 13C20 retinal was prepared by
condensation of citral with 1,3-di-13C acetone and conversion of ketone product to
labelled retinal61.
Solid-state NMR spectroscopy. Solid-state NMR experiments were conducted at
static ﬁeld strengths of either 500 or 600MHz using a 4mm magic angle spinning
(MAS) probe with a spinning rate of 10–12 kHz. NMR measurements were ﬁrst
made on rhodopsin in the dark at  83 C. For Meta- I and -II, the NMR MAS
rotor containing rhodopsin was ejected from the NMR probe, the NMR cap on the
rotor was removed and the sample was illuminated for 1–2min using a 400W
lamp with a 495 nm long-pass ﬁlter at room temperature (Meta-II)62 or 4 C
(Meta-I)38. The cap was then replaced and the rotor inserted into a pre-cooled
NMR probe where the sample temperature was able to reach  83 C within
B5min. We estimate that the conversion from rhodopsin to Meta-I in digitonin is
490% on the basis of ultraviolet/visible absorption and NMR spectra38. After
conversion, we estimate that there is a loss ofo10% of the Meta-I intermediate to
Meta-II and opsin before the sample is cooled to  83 C for NMR
measurements38. We estimate that the conversion from rhodopsin to Meta-II in
DDM is490% and the loss of Meta-II to opsin iso5% before the sample is cooled
to  83 C (ref. 62).
The build-up curves were obtained by collecting DARR NMR spectra as a
function of the mixing time during which magnetization is exchanged. The known
curves were derived from measurements within rhodopsin at ﬁxed distances
(for example, retinal C5-C18, 1.4 Å; C8-C19, C12-C20, 2.4 Å; Cys110 Cb-Cys187
Cb, 3.6 Å; Cys187 Cb-Gly188 Ca, 4.6 Å; Cys187 Cb-Gly188 C¼O, 5.3 Å). Spin
diffusion is limited by the sparse labelling schemes that are typically used.
The NMR assignments were based on mutation and/or mapping out
speciﬁc correlations with unique resonances that have previously been
assigned18,19,34,38,63,64.
All 13C solid-state MAS NMR spectra were externally referenced to the 13C
resonance of neat TMS at 0 p.p.m. at room temperature. Using TMS as the external
reference, we calibrated the carbonyl resonance of solid glycine at 176.46 p.p.m.
The chemical shift difference between 13C of DSS in D2O relative to neat TMS is
2.01 p.p.m. The spectra shown were generally repeated at least twice on samples
puriﬁed from different cell growths without deviations of more than ±0.2 p.p.m.
in the reported chemical shifts.
FTIR spectroscopy. FTIR difference spectroscopy was performed with a Bruker
Vertex 70 spectrometer with a mercury–cadmium–telluride detector22–24. Spectra
were recorded by using time-resolved rapid-scan FTIR methods with a spectral
resolution of 4 cm 1. The wild-type and mutant rhodopsin samples were puriﬁed
from HEK293S cell membranes in DDM and reconstituted at a 1:200 molar ratio
into egg phosphocholine using biobeads for detergent removal. The results shown
in Fig. 4 are for samples in phosphocholine membranes obtained at 0 C. Samples
were prepared by drying solutions of rhodopsin between two CaF2 windows and
then pre-equilibrating the sample with buffer (200mM Bis-Tris propane or MES at
pH 5.0 and 5.5) at the appropriate pH. Photolysis was carried out using an LED
array centred at 530 nm for 1 s, and experiments were performed with an
acquisition time of 12 s.
The conditions for NMR and FTIR are different. For NMR, the analysis relies
on complete conversion (490%) to Meta-I or Meta-II, which is facilitated by
solubilization in digitonin or DDM, respectively. Rhodopsin is monomeric in
DDM and is able to activate the G protein transducin65. Digitonin is unusual in
that its hydrophobic end is composed of a rigid spirostan steroid moiety rather
than ﬂexible fatty acyl chains. The rigid framework effectively blocks the transition
from Meta-I to Meta-II 66. For FTIR, the analysis uses difference methods in which
the FTIR spectrum of Meta-I or Meta-II is subtracted from the spectrum of
rhodopsin. Only the vibrations that change in frequency or intensity contribute to
the difference spectrum. Changes in pH or temperature can be used to shift the
equilibrium between Meta-I and Meta-II. At low temperatures (belowB10 C), the
Meta-I3 Meta-II equilibrium reﬂects a two-state transition in both DDM and
phosphocholine bilayers, which breaks down into a series of Meta-II substates at
higher temperature22,50. In both DDM and phosphocholine bilayers the conversion
to Meta-IIbHþ happens rapidly (millisecond–second timescale) at 20 C
(refs 22,50), which requires the use of time-resolved methods to follow the
transition. For NMR, we convert fully to Meta-II at room temperature, but require
several minutes to low-temperature trap the Meta-II intermediate, which we
assume is predominately Meta-IIbHþ , before it decays.
Data availability. NMR data that support the ﬁndings of this study have been
deposited in the BMRB databank with the accession codes 26812 (rhodopsin) and
26813 (Meta-II) (http://www.bmrb.wisc.edu). The coordinates of Meta-II from the
guided molecular dynamics simulations and remaining data are available on
reasonable request from the corresponding author.
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